Mutational Analysis of Clonality in Multiple Primary Melanoma

多原发性黑色素瘤克隆性的突变分析

• 批准号: 7214248
• 负责人: IRENE ORLOW
• 金额: $ 6.51万
• 依托单位: SLOAN-KETTERING INST CAN RESEARCH
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-09-30 至 2008-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7214248
• 关键词: clinical research; lung; melanoma; neoplasm /cancer

DESCRIPTION (provided by applicant): Melanoma patients are very frequently diagnosed with putative second primaries. Indeed, some patients experience multiple occurrences of the disease. While these phenomena could be explained by strong genetic predisposition, it is also possible that a significant subset of these second and higher-order primaries are actually (clonal) recurrences of the initial primary, since many studies in other sites have occasionally confirmed a clonal origin for new tumors that are presumed to be independent on the basis of classical pathological criteria. Accurate classification of subsequent primaries has important clinical implications, but it is also of considerable relevance for epidemiologic research, since patients with multiple primaries are increasingly being recognized as an important resource, especially for studies of rare genetic factors. Our goal in this study is to conduct a pilot clonality investigation in patients diagnosed with double primary melanoma. Specifically, in order to identify molecular differences and similarities between tumors we propose to: (1) compare the mutational profiles of pairs of primary melanomas from individual patients with double malignancies using micro-satellite instability markers; and (2) reproduce the strategy in Aim 1 using array CGH rather than candidate markers. We will test 25 sets of first and second primary lesions from individuals diagnosed with double primary melanoma. This study will be the first to assess evidence for clonality in multiple primary melanoma. Our results will have implications for the pathologic classification of melanoma, clinical decision making for a patient with a second primary, and epidemiologic research methods. If results from this study suggest that cutaneous metastases are frequently diagnosed as second malignancies, then we will plan a subsequent study using the large population-based resource of tumor tissues from patients with double primary melanoma collected from the international population-based GEM Study (CA83180), designed to determine definitively the frequency of mis-diagnosis, and to determine predictors of tumors that would benefit from mutational profiling to validate the diagnosis.

描述（由申请人提供）： 黑色素瘤患者经常被诊断为第二原发性黑色素瘤。事实上，一些患者经历了该疾病的多次发生。虽然这些现象可以用强遗传倾向来解释，但也有可能这些第二和更高阶原发灶的重要子集实际上是初始原发灶的（克隆）复发，因为其他研究中心的许多研究偶尔证实了新肿瘤的克隆起源，这些肿瘤被认为是独立于经典病理学标准的。随后原发灶的准确分类具有重要的临床意义，但它也与流行病学研究相当相关，因为患有多原发灶的患者越来越被认为是一种重要的资源，特别是对于罕见遗传因素的研究。本研究的目的是对诊断为双原发性黑色素瘤的患者进行初步克隆性研究。具体而言，为了鉴定肿瘤之间的分子差异和相似性，我们提出：（1）使用微卫星不稳定性标记物比较来自患有双重恶性肿瘤的个体患者的成对原发性黑素瘤的突变谱;以及（2）使用阵列CGH而不是候选标记物再现目标1中的策略。我们将测试25组来自诊断为双原发性黑色素瘤的个体的第一和第二原发性病变。这项研究将是第一个评估多原发性黑色素瘤克隆性的证据。我们的研究结果将对黑色素瘤的病理分类、第二原发性黑色素瘤患者的临床决策和流行病学研究方法产生影响。如果本研究的结果表明皮肤转移经常被诊断为继发性恶性肿瘤，则我们将计划使用从基于国际人群的GEM研究（CA 83180）中收集的双原发性黑色素瘤患者的大规模基于人群的肿瘤组织资源进行后续研究，旨在明确确定误诊的频率，并确定肿瘤的预测因子，这些预测因子将受益于突变谱分析以验证诊断。